Incretin/GLP-1 users include many women of childbearing age. We discuss if this can have consequences for pregnancy outcomes.
@ncaresearchnhs.bsky.social
pubmed.ncbi.nlm.nih.gov/42017293/
Posts by akheel sͩyͬed
Acromegaly | New England Journal of Medicine www.nejm.org/doi/full/10....
@safwaanadam.bsky.social and Syed.
We propose a role for incretin therapies in the management of coexisting conditions such as obesity, obstructive sleep apnea, and diabetes..
@ncaresearchnhs.bsky.social
@manchester.ac.uk
In The #Endocrinologist, @safwaanadam.bsky.social and @akheelsyed.bsky.social, describe the various biological effects of obesity in worsening the health of the heart muscle and blood vessels, and how weight loss treatments have benefits for cardiovascular health too. 🫀
Read more👉 shorturl.at/KML5v
Thyroid overactivity worsens patients' quality of life (QoL). After treatment, QoL is not completely restored for many patients. We discuss reasons, and new approaches to address long-term effects on QoL.
@ncaresearchnhs.bsky.social
@endoconnect.bsky.social
www.researchgate.net/publication/...
What's the diagnosis? Be warned: Not everything is as it seems!
Ali, @adhithyasankar.bsky.social, et al. @ncaresearchnhs.bsky.social
www.ccjm.org/content/93/1...
Women under 45 are at increased risk of vitamin D and calcium deficiencies after bariatric surgery.
@ncaresearchnhs.bsky.social
rdcu.be/eYuiy
Accompanying commentary by Nagayama and Yamashita in Thyroid. www.liebertpub.com/doi/10.1177/...
Weight gain after treatment of hyperthyroidism is associated with a large adverse effect on quality of life.
Angelos Kyriacou et al.
@ncaresearchnhs.bsky.social
pubmed.ncbi.nlm.nih.gov/41448910/
Recognising obesity as a primary driver of CVD reinforces the need for early, proactive intervention.
@safwaanadam.bsky.social
@socendocrinology.bsky.social
@ncaresearchnhs.bsky.social
www.endocrinology.org/endocrinolog...
Thymic hyperplasia:
Thymic hyperplasia, common in children and adolescents, is unusual in adults owing to age-related involution.
➡️ www.cmaj.ca/lookup/doi/10.1503/cmaj.250929
Jack Roddy, Shaishav Dhage and Akheel Syed.
@ncaresearchnhs.bsky.social
Treat the Graves' hyperthyroidism and the thymic hyperplasia resolves.
www.cmaj.ca/content/197/...
Long-term outcomes of Roux-en-Y gastric bypass in the adolescent population: a systematic review and single-arm meta-analysis - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
Time for wider adoption of salivary cortisone in endocrinology?
@akheelsyed.bsky.social @addisonsdisease.bsky.social @socendocrinology.bsky.social #AdrenalInsufficiency #Endocrinology #SalivaryCortisone
jamanetwork.com/journals/jam...
Adult Adrenal Insufficiency url: jamanetwork.com/journals/jam...
The role and value of salivary Cortisone test in investigation of Adrenal Insufficiency in adults
More than 2 decades since GLP-1 drugs were introduced, we still don't know why people with diabetes lose about half as much weight as those without diabetes at the same dose
nature.com/articles/s41...
Big randomized trial of a GLP- pill (vs placebo) achieves significant weight loss
www.nejm.org/doi/full/10....
Is that true? Actually, I don't want to know!
Obesity and Metabolic Syndrome: Current Insights and Future Directions. Zaiem Zarkasi, Rajshekhar N. Mudaliar, Waseem A. Majeed, and Akheel A. Syed.
British Journal of Hospital Medicine
www.magonlinelibrary.com/doi/full/10....
“With only one other drug, resmetirom, specifically approved for the treatment of MASH, the new approval of semaglutide, a drug from a well known and widely used class of medications for type 2 diabetes and obesity, is most welcome.”
www.bmj.com/content/390/...
Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance “shake-up”
www.bmj.com/content/390/...
Incretin-based therapies delay gastric emptying and therefore may reduce the absorption of any oral component of HRT. @annicemukherjeemd.bsky.social et al.
pubmed.ncbi.nlm.nih.gov/40378270/
In this study, more than half the patients with hyperthyroidism had ≥10% peak weight gain after treatment. We need to acknowledge, recognise and manage this issue better.
pubmed.ncbi.nlm.nih.gov/40238086/
annicemukherjeemd.bsky.social et al discuss considerations when prescribing incretin-based therapies in women using HRT during the menopause transition and postmenopause; and
thebms.org.uk/2025/04/new-...
Aisha Awan and colleagues argue for nationally funded training programmes for the integration of displaced refugee and asylum seeking healthcare professionals @bmj.com
www.bmj.com/content/388/...
A new way to measure your food intake, from your 💩
www.nature.com/articles/s42...
www.nature.com/articles/s42...
"proof-of-concept for detailed tracking of
individual-specific, health-relevant dietary patterns without the need for questionnaires."
Thanks for sharing 🙏🏻
This review is open access and aimed at all health professionals involved in menopause care
Good, educational case report 👍
As low-grade TPOAb positivity is not uncommon in the background population, was it an innocent bystander with no predictive value for TED? Or a marker of general autoimmune tendency thereby indicating risk for de novo TRAb production?